Latest news

Thumbnail image for EU approves first CAR-T therapies

EU approves first CAR-T therapies

European regulators have approved Novartis’ Kymriah and Gilead’s Yescarta, enabling patients to access CAR-T therapies across the region for the first time.

28th August 2018

Thumbnail image for Sales Awards: Less than two weeks left to enter - do it today

Sales Awards: Less than two weeks left to enter - do it today

The all new Sales Awards will take place at The Tower Hotel, London on Thursday 15 November, alongside the Communications Team of the Year Awards and the 25th anniversary of Marketer of the Year. With the competition closing for entry in just two weeks and spaces filling up fast, PharmaTimes Media is calling on prospective candidates to reserve their places now to avoid missing out.

24th August 2018

Thumbnail image for Communications Team of the Year: Nearly fully booked

Communications Team of the Year: Nearly fully booked

Seize the opportunity to show off your skills and abilities as an agency in the Communications Team of the Year competition. With just one space left in the International Challenge, one in the NHS Challenge and limited availability in the Charity Challenge, agencies wishing to take part should reserve their place now to avoid missing out.

24th August 2018

Thumbnail image for Marketer of the Year: Develop your skills and fulfil your potential

Marketer of the Year: Develop your skills and fulfil your potential

Marketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside Communications Team of the Year and the all-new Sales Awards. Designed to both assess and reward the competencies and potential of pharma marketers, the Marketer of the Year competition identifies and benchmarks marketing talent within pharma organisations against the wider industry.

24th August 2018

Thumbnail image for Roche signs inclacumab deal with GBT

Roche signs inclacumab deal with GBT

Roche has sold off rights to inclacumab to Global Blood Therapeutics, which intends to develop the treatment for vaso-occlusive crises (VOC) in patients with sickle cell disease (SCD).

24th August 2018

Thumbnail image for Sobi secures NHS reimbursement for Ravicti

Sobi secures NHS reimbursement for Ravicti

Rare disease group Swedish Orphan Biovitrum (Sobi) says it has gained NHS England reimbursement for Ravicti for long-term management of urea-cycle disorders (UCDs) in adults and children.

23rd August 2018

Thumbnail image for Novimmune submits lead drug emapalumab in Europe

Novimmune submits lead drug emapalumab in Europe

Swiss biotech Novimmune has submitted a marketing application in Europe seeking permission to market its lead compound emapalumab for the treatment of patients with primary Hemophagocytic Lymphohistiocytosis (HLH).

23rd August 2018

Thumbnail image for AZ mulling over mixed data for Bevespi Aerosphere

AZ mulling over mixed data for Bevespi Aerosphere

AstraZeneca has announced mixed top-line results from the AERISTO Phase IIIb trial for Bevespi Aerosphere in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

23rd August 2018

Previous  --   2 3 4 5 6 7 8 9 10 11   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download